Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Cancer stem cell-associated miRNAs serve as prognostic biomarkers in colorectal cancer.

Toden S, Kunitoshi S, Cardenas J, Gu J, Hutchins E, Van Keuren-Jensen K, Uetake H, Toiyama Y, Goel A.

JCI Insight. 2019 Mar 21;4(6). pii: 125294. doi: 10.1172/jci.insight.125294. eCollection 2019 Mar 21.

2.

TIAM1 promotes chemoresistance and tumor invasiveness in colorectal cancer.

Izumi D, Toden S, Ureta E, Ishimoto T, Baba H, Goel A.

Cell Death Dis. 2019 Mar 19;10(4):267. doi: 10.1038/s41419-019-1493-5.

3.

A genomewide transcriptomic approach identifies a novel gene expression signature for the detection of lymph node metastasis in patients with early stage gastric cancer.

Izumi D, Gao F, Toden S, Sonohara F, Kanda M, Ishimoto T, Kodera Y, Wang X, Baba H, Goel A.

EBioMedicine. 2019 Mar;41:268-275. doi: 10.1016/j.ebiom.2019.01.057. Epub 2019 Feb 13.

4.

A combination of curcumin and oligomeric proanthocyanidins offer superior anti-tumorigenic properties in colorectal cancer.

Ravindranathan P, Pasham D, Balaji U, Cardenas J, Gu J, Toden S, Goel A.

Sci Rep. 2018 Sep 14;8(1):13869. doi: 10.1038/s41598-018-32267-8.

5.

AZIN1 RNA editing confers cancer stemness and enhances oncogenic potential in colorectal cancer.

Shigeyasu K, Okugawa Y, Toden S, Miyoshi J, Toiyama Y, Nagasaka T, Takahashi N, Kusunoki M, Takayama T, Yamada Y, Fujiwara T, Chen L, Goel A.

JCI Insight. 2018 Jun 21;3(12). pii: 99976. doi: 10.1172/jci.insight.99976. eCollection 2018 Jun 21.

6.

Mechanistic insights into anticancer properties of oligomeric proanthocyanidins from grape seeds in colorectal cancer.

Ravindranathan P, Pasham D, Balaji U, Cardenas J, Gu J, Toden S, Goel A.

Carcinogenesis. 2018 May 28;39(6):767-777. doi: 10.1093/carcin/bgy034.

7.

Oligomeric proanthocyanidins (OPCs) target cancer stem-like cells and suppress tumor organoid formation in colorectal cancer.

Toden S, Ravindranathan P, Gu J, Cardenas J, Yuchang M, Goel A.

Sci Rep. 2018 Feb 20;8(1):3335. doi: 10.1038/s41598-018-21478-8.

8.

The Holy Grail of Curcumin and its Efficacy in Various Diseases: Is Bioavailability Truly a Big Concern?

Toden S, Goel A.

J Restor Med. 2017 Dec;6(1):27-36. doi: 10.14200/jrm.2017.6.0101.

9.

Curcumin sensitizes pancreatic cancer cells to gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1 expression.

Yoshida K, Toden S, Ravindranathan P, Han H, Goel A.

Carcinogenesis. 2017 Oct 1;38(10):1036-1046. doi: 10.1093/carcin/bgx065.

10.

SNORA21 - An Oncogenic Small Nucleolar RNA, with a Prognostic Biomarker Potential in Human Colorectal Cancer.

Yoshida K, Toden S, Weng W, Shigeyasu K, Miyoshi J, Turner J, Nagasaka T, Ma Y, Takayama T, Fujiwara T, Goel A.

EBioMedicine. 2017 Aug;22:68-77. doi: 10.1016/j.ebiom.2017.07.009. Epub 2017 Jul 12.

11.

Essential turmeric oils enhance anti-inflammatory efficacy of curcumin in dextran sulfate sodium-induced colitis.

Toden S, Theiss AL, Wang X, Goel A.

Sci Rep. 2017 Apr 11;7(1):814. doi: 10.1038/s41598-017-00812-6.

12.

MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer.

Miyoshi J, Toden S, Yoshida K, Toiyama Y, Alberts SR, Kusunoki M, Sinicrope FA, Goel A.

Sci Rep. 2017 Mar 6;7:43393. doi: 10.1038/srep43393.

13.

Circular RNA ciRS-7-A Promising Prognostic Biomarker and a Potential Therapeutic Target in Colorectal Cancer.

Weng W, Wei Q, Toden S, Yoshida K, Nagasaka T, Fujiwara T, Cai S, Qin H, Ma Y, Goel A.

Clin Cancer Res. 2017 Jul 15;23(14):3918-3928. doi: 10.1158/1078-0432.CCR-16-2541. Epub 2017 Feb 7.

14.

Aspirin-Induced Chemoprevention and Response Kinetics Are Enhanced by PIK3CA Mutations in Colorectal Cancer Cells.

Zumwalt TJ, Wodarz D, Komarova NL, Toden S, Turner J, Cardenas J, Burn J, Chan AT, Boland CR, Goel A.

Cancer Prev Res (Phila). 2017 Mar;10(3):208-218. doi: 10.1158/1940-6207.CAPR-16-0175. Epub 2017 Feb 2.

15.

Emerging Role of MicroRNAs as Liquid Biopsy Biomarkers in Gastrointestinal Cancers.

Shigeyasu K, Toden S, Zumwalt TJ, Okugawa Y, Goel A.

Clin Cancer Res. 2017 May 15;23(10):2391-2399. doi: 10.1158/1078-0432.CCR-16-1676. Epub 2017 Jan 31. Review.

16.

Exportin-5 Functions as an Oncogene and a Potential Therapeutic Target in Colorectal Cancer.

Shigeyasu K, Okugawa Y, Toden S, Boland CR, Goel A.

Clin Cancer Res. 2017 Mar 1;23(5):1312-1322. doi: 10.1158/1078-0432.CCR-16-1023. Epub 2016 Aug 23.

17.

Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.

Imaoka H, Toiyama Y, Fujikawa H, Hiro J, Saigusa S, Tanaka K, Inoue Y, Mohri Y, Mori T, Kato T, Toden S, Goel A, Kusunoki M.

Ann Oncol. 2016 Oct;27(10):1879-86. doi: 10.1093/annonc/mdw279. Epub 2016 Aug 8.

PMID:
27502702
18.

FOXM1 and FOXQ1 Are Promising Prognostic Biomarkers and Novel Targets of Tumor-Suppressive miR-342 in Human Colorectal Cancer.

Weng W, Okugawa Y, Toden S, Toiyama Y, Kusunoki M, Goel A.

Clin Cancer Res. 2016 Oct 1;22(19):4947-4957. Epub 2016 May 9.

19.

miRNA-503 Promotes Tumor Progression and Is Associated with Early Recurrence and Poor Prognosis in Human Colorectal Cancer.

Noguchi T, Toiyama Y, Kitajima T, Imaoka H, Hiro J, Saigusa S, Tanaka K, Inoue Y, Mohri Y, Toden S, Kusunoki M.

Oncology. 2016;90(4):221-31. doi: 10.1159/000444493. Epub 2016 Mar 22.

PMID:
26999740
20.

Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer.

Toden S, Tran HM, Tovar-Camargo OA, Okugawa Y, Goel A.

Oncotarget. 2016 Mar 29;7(13):16158-71. doi: 10.18632/oncotarget.7567.

21.

Exosomal microRNA Biomarkers: Emerging Frontiers in Colorectal and Other Human Cancers.

Tovar-Camargo OA, Toden S, Goel A.

Expert Rev Mol Diagn. 2016;16(5):553-67. doi: 10.1586/14737159.2016.1156535. Epub 2016 Mar 16. Review.

22.

Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer.

Okugawa Y, Toiyama Y, Toden S, Mitoma H, Nagasaka T, Tanaka K, Inoue Y, Kusunoki M, Boland CR, Goel A.

Gut. 2017 Jan;66(1):107-117. doi: 10.1136/gutjnl-2015-309359. Epub 2015 Oct 15.

23.

Novel Evidence for Curcumin and Boswellic Acid-Induced Chemoprevention through Regulation of miR-34a and miR-27a in Colorectal Cancer.

Toden S, Okugawa Y, Buhrmann C, Nattamai D, Anguiano E, Baldwin N, Shakibaei M, Boland CR, Goel A.

Cancer Prev Res (Phila). 2015 May;8(5):431-43. doi: 10.1158/1940-6207.CAPR-14-0354. Epub 2015 Feb 23.

24.

Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer.

Toden S, Okugawa Y, Jascur T, Wodarz D, Komarova NL, Buhrmann C, Shakibaei M, Boland CR, Goel A.

Carcinogenesis. 2015 Mar;36(3):355-67. doi: 10.1093/carcin/bgv006. Epub 2015 Feb 4.

25.

Butyrylated starch affects colorectal cancer markers beneficially and dose-dependently in genotoxin-treated rats.

Toden S, Lockett TJ, Topping DL, Scherer BL, Watson EJ, Southwood JG, Clarke JM.

Cancer Biol Ther. 2014;15(11):1515-23. doi: 10.4161/15384047.2014.955764.

26.

The importance of diets and epigenetics in cancer prevention: a hope and promise for the future?

Toden S, Goel A.

Altern Ther Health Med. 2014 Oct;20 Suppl 2:6-11.

PMID:
25362211
27.

Metastasis-associated long non-coding RNA drives gastric cancer development and promotes peritoneal metastasis.

Okugawa Y, Toiyama Y, Hur K, Toden S, Saigusa S, Tanaka K, Inoue Y, Mohri Y, Kusunoki M, Boland CR, Goel A.

Carcinogenesis. 2014 Dec;35(12):2731-9. doi: 10.1093/carcin/bgu200. Epub 2014 Oct 3.

28.

Resistant starches protect against colonic DNA damage and alter microbiota and gene expression in rats fed a Western diet.

Conlon MA, Kerr CA, McSweeney CS, Dunne RA, Shaw JM, Kang S, Bird AR, Morell MK, Lockett TJ, Molloy PL, Regina A, Toden S, Clarke JM, Topping DL.

J Nutr. 2012 May;142(5):832-40. doi: 10.3945/jn.111.147660. Epub 2012 Mar 28.

29.

Colonocyte telomere shortening is greater with dietary red meat than white meat and is attenuated by resistant starch.

O'Callaghan NJ, Toden S, Bird AR, Topping DL, Fenech M, Conlon MA.

Clin Nutr. 2012 Feb;31(1):60-4. doi: 10.1016/j.clnu.2011.09.003. Epub 2011 Oct 1.

PMID:
21963168
30.

Effects of dietary beef and chicken with and without high amylose maize starch on blood malondialdehyde, interleukins, IGF-I, insulin, leptin, MMP-2, and TIMP-2 concentrations in rats.

Toden S, Belobrajdic DP, Bird AR, Topping DL, Conlon MA.

Nutr Cancer. 2010;62(4):454-65. doi: 10.1080/01635580903532382.

PMID:
20432166
31.

Can indole-based extracts prevent colorectal cancer via early apoptotic pathways?

Toden S, Scherer BL, Clarke JM.

Cancer Biol Ther. 2010 Mar 1;9(5):380-2. Epub 2010 Mar 1. Review. No abstract available.

PMID:
20168074
32.

High red meat diets induce greater numbers of colonic DNA double-strand breaks than white meat in rats: attenuation by high-amylose maize starch.

Toden S, Bird AR, Topping DL, Conlon MA.

Carcinogenesis. 2007 Nov;28(11):2355-62. Epub 2007 Oct 4.

PMID:
17916911
33.
34.
35.

Resistant starch prevents colonic DNA damage induced by high dietary cooked red meat or casein in rats.

Toden S, Bird AR, Topping DL, Conlon MA.

Cancer Biol Ther. 2006 Mar;5(3):267-72. Epub 2006 Mar 5.

PMID:
16410726
36.

Resistant starch attenuates colonic DNA damage induced by higher dietary protein in rats.

Toden S, Bird AR, Topping DL, Conlon MA.

Nutr Cancer. 2005;51(1):45-51.

PMID:
15749629

Supplemental Content

Support Center